Cargando…

Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study

BACKGROUND AND AIMS: Fibroblasts growth factor 21 (FGF21), a liver-secreted endocrine factor involved in regulating glucose and lipid metabolism, has been shown to be elevated in patients with non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the quantitative correlation betwee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Hongmei, Xia, Mingfeng, Chang, Xinxia, Xu, Qiong, Bian, Hua, Zeng, Mengsu, Rao, Shengxiang, Yao, Xiuzhong, Tu, Yinfang, Jia, Weiping, Gao, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174975/ https://www.ncbi.nlm.nih.gov/pubmed/21949781 http://dx.doi.org/10.1371/journal.pone.0024895

Ejemplares similares

Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
por: Yang, Xinyu, et al.
Publicado: (2021)

Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study
por: Yan, Hongmei, et al.
Publicado: (2013)

Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study
por: Chang, Xinxia, et al.
Publicado: (2015)

DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
por: Zhu, Xiaopeng, et al.
Publicado: (2020)

Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans
por: Bai, Jinyun, et al.
Publicado: (2020)

Comparison of Biexponential and Monoexponential Model of Diffusion-Weighted Imaging for Distinguishing between Common Renal Cell Carcinoma and Fat Poor Angiomyolipoma
por: Ding, Yuqin, et al.
Publicado: (2016)

Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases
por: Wu, Liang, et al.
Publicado: (2017)

The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis
por: Magdas, Arsenios, et al.
Publicado: (2019)

Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2015)

Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
por: Li, Huating, et al.
Publicado: (2018)

Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
por: Knott, ME, et al.
Publicado: (2016)

Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation
por: Zhu, Xiaopeng, et al.
Publicado: (2020)

Serum retinol binding protein 4 is negatively related to estrogen in Chinese women with obesity: a cross-sectional study
por: Li, Qian, et al.
Publicado: (2016)

Circulating FGF21 proteolytic processing mediated by fibroblast activation protein
por: Zhen, Eugene Y., et al.
Publicado: (2016)

A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease
por: Yang, Xinyu, et al.
Publicado: (2022)

FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c
por: Wang, Liu, et al.
Publicado: (2019)

Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation
por: Ye, Dewei, et al.
Publicado: (2016)

Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y Gastric Bypass in Chinese obese patients with BMI 28–35 kg/m(2) and Type 2 diabetes: a 6-month follow-up
por: Tu, Yinfang, et al.
Publicado: (2015)

Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat Cells
por: Wang, Yongliang, et al.
Publicado: (2015)

Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation
por: Tanimura, Yuko, et al.
Publicado: (2016)

Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer
por: Kang, Yea Eun, et al.
Publicado: (2019)

Genome-wide association study for circulating fibroblast growth factor 21 and 23
por: Chuang, Gwo-Tsann, et al.
Publicado: (2020)

Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
por: Chang, Xinxia, et al.
Publicado: (2016)

Circulating Pancreatic Polypeptide Concentrations Predict Visceral and Liver Fat Content
por: Sam, Amir H., et al.
Publicado: (2015)

Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
por: Qian, Jing, et al.
Publicado: (2018)

Liver fat content is independently associated with microalbuminuria in a normotensive, euglycaemic Chinese population: a community-based, cross-sectional study
por: Li, Xiaoming, et al.
Publicado: (2021)

Liver Fat Content, Evaluated through Semi-Quantitative Ultrasound Measurement, Is Associated with Impaired Glucose Profiles: A Community-Based Study in Chinese
por: Li, Xiaoming, et al.
Publicado: (2013)

Insulin Glargine is More Suitable Than Exenatide in Preventing Muscle Loss in Non-Obese Type 2 Diabetic Patients with NAFLD
por: Liu, Lin, et al.
Publicado: (2023)

Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas
por: Singhal, Garima, et al.
Publicado: (2016)

Circulating Non-Esterified Fatty Acids as Biomarkers for Fat Content and Composition in Pigs
por: Tor, Marc, et al.
Publicado: (2021)

Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study
por: Liang, Liang, et al.
Publicado: (2021)

Close association between lifestyle and circulating FGF21 levels: A systematic review and meta-analysis
por: Qian, Zonghao, et al.
Publicado: (2022)

Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris
por: Cheng, Jing, et al.
Publicado: (2018)

Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
por: Kohara, Marina, et al.
Publicado: (2017)

Single Nucleotide Polymorphisms in Close Proximity to the Fibroblast Growth Factor 21 (FGF21) Gene Found to Be Associated with Sugar Intake in a Swedish Population
por: Janzi, Suzanne, et al.
Publicado: (2021)

Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
por: Yan, Hongmei, et al.
Publicado: (2021)

Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression
por: Zhu, Xiaopeng, et al.
Publicado: (2018)

Hepatic Angiomyolipoma with Minimal Intratumoral Fat Content
por: Banshodani, Masataka, et al.
Publicado: (2009)

Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
por: Li, Xinyue, et al.
Publicado: (2021)

Obesity-Induced Hepatic Steatosis Is Partly Mediated by Visceral Fat Accumulation in Subjects with Overweight/Obesity: A Cross-Sectional Study
por: Liu, Fengjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7dj9tmfl2tl4hrr3tvecemsts4